Language selection

Search

Details for: VIMOVO

Company: XEDITON PHARMACEUTICALS INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02361701VIMOVONAPROXEN; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)375 MG; 20 MGTABLET (IMMEDIATE AND DELAYED-RELEASE)ORAL
02361728VIMOVONAPROXEN; ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM TRIHYDRATE)500 MG; 20 MGTABLET (IMMEDIATE AND DELAYED-RELEASE)ORAL
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: